Central Cancer Registry Reporting Content IG
2.0.0-ballot - STU 2 Ballot

Central Cancer Registry Reporting Content IG - Downloaded Version 2.0.0-ballot See the Directory of published versions

## : Cancer Related Medication Administration - Example - JSON Representation

Page standards status: Informative

Raw json | Download

    {
      "resourceType" : "MedicationAdministration",
      "id" : "cancer-med-admin-docetaxel-example",
      "meta" : {
        "profile" : [
          🔗 "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"
        ]
      },
      "text" : {
        "status" : "generated",
        "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Profile: </b> <a href=\"https://hl7.org/fhir/us/mcode/StructureDefinition-mcode-cancer-related-medication-administration.html\">mCODE Cancer Related Medication Administration</a></p><p><b>status:</b> completed</p><p><b>category:</b> Outpatient</p><p><b>medication:</b> rxnorm 72962 docetaxel</p><p><b>subject:</b> <a href=\"Patient-example.html\">Patient-example: Amy Shaw</a></p><p><b>start date:</b> 2023-04-10</p><p><b>Performer:</b> Joseph Nichols</p><p><b>reasonReference:</b> Condition-primary-cancer-condition-breast</p><p><b>authoredOn:</b> 2023-04-10</p><p><b>note:</b> Chemotherapy regimen of docetaxel, carboplatin, adriamycin, cyclophosphamide, and paclitaxel administered by continuous infusion. Patient tolerated infusion without side effects.</p><p><b>Route:</b> SNOMED 47625008 Intravenous route (qualifier value)</p></div>"
      },
      "status" : "completed",
      "category" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/medication-admin-category",
            "code" : "outpatient"
          }
        ]
      },
      "medicationCodeableConcept" : {
        "coding" : [
          {
            "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code" : "72962",
            "display" : "docetaxel"
          }
        ]
      },
      "subject" : {
        🔗 "reference" : "Patient/example"
      },
      "effectiveDateTime" : "2023-04-10",
      "performer" : [
        {
          "actor" : {
            🔗 "reference" : "Practitioner/1"
          }
        }
      ],
      "reasonCode" : [
        {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "408643008",
              "display" : "Infiltrating duct carcinoma of breast (disorder)"
            }
          ]
        }
      ],
      "reasonReference" : [
        {
          🔗 "reference" : "Condition/primary-cancer-condition-breast"
        }
      ],
      "note" : [
        {
          "authorReference" : {
            🔗 "reference" : "Practitioner/1"
          },
          "time" : "2023-04-10",
          "text" : "docetaxel administered by continuous infusion. Patient tolerated infusion without side effects."
        }
      ],
      "dosage" : {
        "route" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "47625008",
              "display" : "Intravenous route (qualifier value)"
            }
          ]
        },
        "dose" : {
          "value" : 60,
          "unit" : "mg",
          "system" : "http://unitsofmeasure.org",
          "code" : "mg"
        }
      }
    }